QIMR Berghofer-led research in collaboration with Australian oncology company Kazia Therapeutics has found that combining the drug candidate paxalisib with immunotherapy triggered a molecular ...

Desperate times call for creative solutions, and Chinese cat owners are proving this by repurposing COVID-19 medication to ...

B-cells are a vital part of the immune system, and although this drug combination will destroy the cells while the patient is on treatment, the body should begin producing them again once treatment is ...

† School of Chemical Engineering, Nanjing University of Science and Technology, Nanjing 210094, People’s Republic of China ‡ National Special Superfine Powder Engineering Research Centre, Nanjing ...

BeiGene (NASDAQ:ONC) (OTCPK:BEIGF) announced that an advisory committee of the European Medicines Agency (EMA), endorsed its Tevimbra combination treatment for patients with nasopharyngeal cancer.

Biomaterial Research Laboratory, Department of Material Science and Engineering, College of Chemistry and Materials, Jinan University, Guangzhou 510632, P. R. China Biomaterial Research Laboratory, ...

CHICAGO, May 20, 2025--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine ... evaluated the combination of avutometinib ...

The combination treatment (c4G12 plus ca1C5) was well-tolerated, and evidence of antitumor activity was observed in one dog with oral malignant melanoma. Further studies are warranted to advance ...

Data from the core, randomised stage of Beckley Psytech’s Phase IIb study of BPL-003 for treatment resistant depression is expected in mid-2025. OXFORD, UNITED KINGDOM – 20 MAY 2025. Beckley Psytech ...

In a new study led by the Cleveland Clinic, researchers trialed the combination of an existing cholesterol medication with a brand-new one and found that, together, the drugs lowered LDL ...